'Modeling' relationships among HIV-1 replication, immune activation and CD4+ T-cell losses using adjusted correlative analyses
- PMID: 10853976
- DOI: 10.1097/00002030-200005260-00006
'Modeling' relationships among HIV-1 replication, immune activation and CD4+ T-cell losses using adjusted correlative analyses
Abstract
Objective: To model the relationships among HIV-1 replication, immune activation and CD4+ T-cell losses in HIV-1 infection.
Methods: Cross-sectional analysis of baseline data from the Viral Activation by Transfusion Study. Comparisons of unadjusted and adjusted correlative analyses to establish models for mechanisms of cell loss in AIDS.
Results: Using these analyses, significant correlations were found among plasma levels of tumor necrosis factor alpha (TNFalpha) and its type two receptor (TNFrII), interleukin-6 (IL-6), beta2-microglobulin, expression of CD38 and HLA-DR on CD8+ T lymphocytes and plasma levels of HIV-1 RNA. When correlations among these indices were adjusted for possible intermediary correlations, the relationship between HIV-1 RNA levels and all plasma markers of immune activation could be accounted for by the correlation between plasma HIV-1 RNA and plasma TNFrII levels. In addition, the negative correlations that both HIV-1 RNA levels and TNFrII levels had with CD4+ T-cell counts were partially accounted for by the correlations of HIV-1 RNA and TNFrII with CD38 expression on CD8+ T cells. In persons with advanced disease (CD4+ T cells < 50 x 10(6)/l) IL-6 levels were inversely correlated with CD4+ T-cell counts.
Conclusions: This analysis is consistent with a model wherein HIV-1 replication induces TNFalpha expression that induces multiple other indices of immune activation. In this model, HIV-1 replication and TNFalpha expression induce CD4+ T-cell losses at least in part through mechanisms reflected in heightened CD38 expression.
Similar articles
-
Activation of CD8 T cells normalizes and correlates with the level of infectious provirus in tonsils during highly active antiretroviral therapy in early HIV-1 infection.AIDS. 1999 Dec 3;13(17):2365-76. doi: 10.1097/00002030-199912030-00008. AIDS. 1999. PMID: 10597778
-
Elevated CD38 antigen expression on CD8+ T cells is a stronger marker for the risk of chronic HIV disease progression to AIDS and death in the Multicenter AIDS Cohort Study than CD4+ cell count, soluble immune activation markers, or combinations of HLA-DR and CD38 expression.J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Oct 1;16(2):83-92. doi: 10.1097/00042560-199710010-00003. J Acquir Immune Defic Syndr Hum Retrovirol. 1997. PMID: 9358102
-
Immunological benefits of antiretroviral therapy in very early stages of asymptomatic chronic HIV-1 infection.AIDS. 2000 Sep 8;14(13):1921-33. doi: 10.1097/00002030-200009080-00007. AIDS. 2000. PMID: 10997396 Clinical Trial.
-
Role of CD38 in HIV-1 infection: an epiphenomenon of T-cell activation or an active player in virus/host interactions?AIDS. 2000 Jun 16;14(9):1079-89. doi: 10.1097/00002030-200006160-00004. AIDS. 2000. PMID: 10894271 Review. No abstract available.
-
Novel mechanism for the impairment of cell proliferation in HIV-1 infection.Immunol Today. 1999 Jun;20(6):258-61. doi: 10.1016/s0167-5699(99)01471-1. Immunol Today. 1999. PMID: 10354550 Review.
Cited by
-
Study design issues in evaluating immune biomarkers.Curr Opin HIV AIDS. 2013 Mar;8(2):147-54. doi: 10.1097/COH.0b013e32835d3259. Curr Opin HIV AIDS. 2013. PMID: 23380656 Free PMC article. Review.
-
Increased T-cell activation and Th1 cytokine concentrations prior to the diagnosis of B-cell lymphoma in HIV infected patients.J Clin Immunol. 2013 Jan;33(1):22-9. doi: 10.1007/s10875-012-9766-0. Epub 2012 Aug 23. J Clin Immunol. 2013. PMID: 22914896
-
Low Incidence of HIV-1C Acquired Drug Resistance 10 Years after Roll-Out of Antiretroviral Therapy in Ethiopia: A Prospective Cohort Study.PLoS One. 2015 Oct 29;10(10):e0141318. doi: 10.1371/journal.pone.0141318. eCollection 2015. PLoS One. 2015. PMID: 26512902 Free PMC article.
-
Immune activation and IL-12 production during acute/early HIV infection in the absence and presence of highly active, antiretroviral therapy.J Leukoc Biol. 2008 Dec;84(6):1447-53. doi: 10.1189/jlb.0708438. Epub 2008 Sep 19. J Leukoc Biol. 2008. PMID: 18806124 Free PMC article.
-
Activation and coagulation biomarkers are independent predictors of the development of opportunistic disease in patients with HIV infection.J Infect Dis. 2009 Sep 15;200(6):973-83. doi: 10.1086/605447. J Infect Dis. 2009. PMID: 19678756 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials